Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin’s lymphoma

Published:1998-06 Issue:6 Volume:9 Page:633-638
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bailey N.P.,Stuart N.S.A.,Bessell E.M.,Child J.A.,Norfolk D.,Fletcher J.,Grieve R.J.,Simmons A.V.,Barnard D.L.,Jack A.,Farish J.,Dunn J.,Woodroffe C.M.,Stack C.,Cullen M.H.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/9/6/633/19481810/9-6-633.pdf

Reference19 articles.

1. Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen;Armitage;J Clin Oncol,1984

2. Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD;Shipp;Ann Intern Med,1986

3. Randomised comparison of MACOP-B with CHOP in patients with intermediate grade non-Hodgkin’s lymphoma. The Australian and New Zealand Lymphoma Group;Cooper;J Clin Oncol,1994

4. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate;Goldie;Cancer Treat Rep,1979

5. The importance of dose intensity in the chemotherapy of metastatic breast cancer;Hryniuk;J Clin Oncol,1984

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma;Leukemia & Lymphoma;2013-04-17

2. Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points;Annals of Oncology;2011-06

3. Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones;European Journal of Medicinal Chemistry;2010-05

4. Lymphoma in Older Patients;Journal of Clinical Oncology;2007-05-10

5. Treatment Paradigms in Aggressive Non-Hodgkin's Lymphoma in Elderly Patients;Clinical Lymphoma;2002-12